Novel Combo Promising in Advanced HER2-Negative Breast Cancer - Medpage Today

Поделиться
HTML-код
  • Опубликовано: 15 сен 2024
  • ORR of 30% supports deeper evaluation of entinostat-nivolumab-ipilimumab regimen

Комментарии •